Back to announcement
20240821_DGNS_Laporan Informasi dan Fakta Material_31707564_lamp1.pdf
Board change Needs review DGNSSource file signed link, expires in 15 minutes
Extracted text 1
Page 1
Agus Heru Darjono
A professional in Corporate Strategy, Marketing, Seorang professional di bidang Strategi
Organizational Development, and Human Korporasi, Pemasaran, Pengembangan
Resource Development with more than 30 years Organisasi, dan Pengembangan Sumber Daya
of experience in the pharmaceutical industry. Manusia dengan pengalaman lebih dari 30 tahun
Starting his career as a medical representative di industri farmasi. Mengawali karirnya sebagai
to the highest decision-making corporate medical representative sampai dengan
strategy as a director in several leading pengambilan keputusan tertinggi strategi
pharmaceutical companies in Indonesia. korporasi sebagai direktur di beberapa
perusahaan farmasi terkemuka di Indonesia.
In the EGMS 2024, he will be nominated as Pada RUPS Luar Biasa 2024 beliau diusulkan
Commissioner of the Company. untuk diangkat sebagai Komisaris Perseroan.
Education
2019 : IPB University School of Business – Doctoral
2005 : PPM School of Management Jakarta - Magister Management
2001 : STIE PBM Jakarta – Bachelor of Management
Career
1990 - 1993 : Medical Representative of PT Pfizer Indonesia
1994 - 1995 : Senior Medical Representative of PT Pfizer Indonesia
1996 - 1997 : District Manager of PT Pfizer Indonesia
1998 - 2000 : Field Training Manager of PT Pfizer Indonesia
2001 - 2005 : Sales Training Manager of PT Pfizer Indonesia
2006 : Sales Manager – PT Pfizer Indonesia
2007 : Sales Training and Development Manager of PT Pfizer Indonesia
2007 - 2008 : Sales Force Effectiveness Manager of PT Pfizer Indonesia
2008 : Organization Effectiveness Manager of PT Pfizer Indonesia
2009 - 2011 : Business Operation and Strategic Planning Director of PT Pfizer Indonesia
2011 : Regional Learning and Development of Pfizer APAC Region
2011 – 2012 : Marketing Director of PT Pfizer Indonesia
2012 – 2014 : Commercial Operation and Development Director of PT Merck Sharp and Dohme
2014 : Organization Development Director of PT Darya Varia Laboratoria –Unilab
2015 – 2017 : Human Resources and Development Director – PT Darya Varia Laboratoria-Unilab
2017 – 2018 : President Director of PT Metro Drug Indonesia – Zuellig Group
2018 – 2019 : Chief Operating Officer Commercial of PT Anugrah Pharmindo Lestari – Zuellig Pharma
2020 – 2021 : Vice President of PT Bernofarm Group – Pharmaceutical Company
2021 – 2023 : Corporate Strategy Director of PT Darya Varia Laboratoria
2023 : President Director of PT Indofarma (Persero) Tbk
2024 – now : President Director of PT Bundamedik Tbk
2024 – now : Vice President Director of PT Morula Indonesia
BMHS 2024 1
Names mentioned 11 people and organisations named in the text · linked when the evidence is strong
unresolved
org
PT Pfizer Indonesia
p.1 ×11
unresolved
org
PT Merck Sharp
p.1
unresolved
org
PT Darya Varia Laboratoria-Unilab
p.1
unresolved
org
PT Metro Drug Indonesia
p.1
unresolved
org
PT Anugrah Pharmindo Lestari
p.1
unresolved
org
PT Bernofarm Group
p.1
unresolved
org
PT Morula Indonesia BMHS
p.1
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
Rule parser
Needs review
confidence 0.100
1014 ms
12 Sep 2026 22:59
no e-reporting cover - issuer taken from the announcement
Raw output
{'announced_date': None,
'changes': [],
'event_date': None,
'issuer_name': 'PT Bundamedik Tbk',
'issuer_ticker': '',
'letter_number': '',
'positions': [],
'source_shape': 'ROSTER',
'subject': ''}